Robert Grimshaw

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 306 citations · Full text

Medicine, Oncology, Surgery +13

Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Paul Hoskins, Elizabeth A. Eisenhauer, Sandra Beare et al. · Journal of Clinical Oncology · 1998 · 172 citations

Medicine, Oncology, Pharmacology +17

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study

Hal W. Hirte, Ignace Vergote, John Jeffrey et al. · Gynecologic Oncology · 2006 · 149 citations

Medicine, Gynecology, Oncology +14

A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study

James Biagi, Amit M. Oza, Haji Chalchal et al. · Annals of Oncology · 2010 · 134 citations · Full text

Medicine, Gynecology, Oncology +17

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

Martine Piccart, K. Bertelsen, Gavin Stuart et al. · International Journal of Gynecological Cancer · 2003 · 122 citations

Medicine, Gynecology, Oncology +13